Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-01 Sale |
2023-11-03 4:39 pm |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
21,619 | $13.84 | $299,309 | 1,538,070 (Indirect Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 5:07 pm |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
20,245 | $14.82 | $300,026 | 1,559,689 (Indirect Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 5:22 pm |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
15,000 | $19.98 | $299,700 | 1,579,934 (Indirect Direct) |
View |
| 2023-05-11 Sale |
2023-05-15 8:34 pm |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
45,000 | $20.68 | $930,656 | 1,594,934 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-28 Tax Withholding |
2024-03-01 4:40 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner |
2,119 | $6.27 | 1,453,244 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 4:44 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner |
12,950 | $0 | 1,455,363 (Direct) |
View |
| 2024-02-27 Tax Withholding |
2024-02-29 4:44 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner |
3,154 | $6.44 | 1,455,363 (Direct) |
View |
| 2024-01-05 Tax Withholding |
2024-01-09 5:00 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner |
4,322 | $5.13 | 1,533,748 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-02 4:18 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
3,113 | $28 | 1,639,934 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:18 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
70,900 | $0 | 1,639,934 (Direct) |
View |
| 2023-01-23 Tax Withholding |
2023-01-24 6:13 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
3,732 | $33.64 | 1,572,147 (Direct) |
View |
| 2023-01-05 Tax Withholding |
2023-01-09 4:33 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
3,827 | $29.26 | 1,575,879 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 6:02 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
34,800 | $0 | 1,579,706 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 4:54 pm |
N/A 2021-05-02 |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
31,201 | $0 | 1,544,906 (Direct) |
View |
| 2021-02-23 Gift |
2021-04-05 4:54 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
16,340 | $0 | 1,544,906 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 4:54 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
31,201 | $8.78 | 1,544,906 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-05 4:54 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
16,278 | $41.87 | 1,544,906 (Direct) |
View |
| 2021-01-23 Tax Withholding |
2021-01-26 6:31 pm |
N/A N/A |
EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner |
4,631 | $47.7 | 1,546,323 (Direct) |
View |